Orkambi, a New Cystic Fibrosis Drug, Wins F.D.A. Approval

The drug is the second one brought to market by Vertex and could be effective for more patients than the first drug, Kalydeco.











from NYT > Health http://ift.tt/1LYu3yq
via health&fitness